Unknown

Dataset Information

Clinical exome sequencing in neurologic disease.


ABSTRACT:

Purpose of review

The landscape of genetic diagnostic testing has changed dramatically with the introduction of next-generation clinical exome sequencing (CES), which provides an unbiased analysis of all protein-coding sequences in the roughly 21,000 genes in the human genome. Use of this testing, however, is currently limited in clinical neurologic practice by the lack of a framework for appropriate use and payer coverage.

Recent findings

CES can be cost-effective due to its high diagnostic yield in comparison to other genetic tests in current use and should be utilized as a routine diagnostic test in patients with heterogeneous neurologic phenotypes facing a broad genetic differential diagnosis. CES can eliminate the need for escalating sequences of conventional neurodiagn

SUBMITTER: Fogel BL 

PROVIDER: S-EPMC4828678 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature